Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Anti-tumor effects of rivoceranib against canine melanoma and mammary gland tumour in vitro and in vivo mouse xenograft models

Fig. 3

Effects of rivoceranib on the migration of canine solid tumour cell lines in vitro. A Cell migration abilities of LMeC and CHMp were measured at 0, 12, and 24 h of rivoceranib treatment. B Histograms showing the relative gap size of the control group at 0 h after rivoceranib treatment. The data represent the mean ± standard deviation obtained from three independent experiments. * p < 0.05, ** p < 0.01

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us